glp 1 and dementia prevention Blood Flow to Brain Function: How GLP-1 Therapies May Reduce Risk Blood Flow to Brain Function:

In this Huberman Lab episode, my guest is Zachary Knight, Ph.D., a professor of physiology at the University of California, San Francisco (UCSF), and Howard Hughes Medical Institute (HHMI) investigator.

Meals and snacks with GLP-1 Friendly labels on the packaging are becoming more common in U.S

Wondering about GLP-1 dosing approaches

Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist

As global demand rises for effective metabolic therapies, GLP-1 drug development remains one of the fastest-growing segments in biopharma innovation